##Brexit backlash: UK patients pulled from international heart drug trial

###Brexit backlash: UK patients pulled from international heart drug trial | #MIDDAY

Heart patients across the U.K. have been cut from an international clinical trial to test a novel heart attack drug after the medicine’s manufacturers expressed concern about registering new medications in Europe post-Brexit.

Patients in Exeter, Leeds and Clydebank, in Scotland, were slated to participate in the trial, the Independent reported this month. However, U.S. pharmaceutical company Recardio backed out of the British arm of its trial due to worries that the European Medicines Agency would have trouble accepting British data after Brexit clears.
 

Read The Rest at Health UK, United Kingdom Healthy News